RAPIDLY-DISSOLVING PHARMACEUTICAL COMPOSITION FOR INHIBITING OVULATION
A rapidly-dissolving oral dosage pharmaceutical composition for inhibiting ovulation in a mammal, said composition comprising drospirenone or a pharmaceutically acceptable salt or ester thereof, optionally ethinyl estradiol or a pharmaceutically acceptable salt, ester or ether thereof, a surfactant...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
29.03.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A rapidly-dissolving oral dosage pharmaceutical composition for inhibiting ovulation in a mammal, said composition comprising drospirenone or a pharmaceutically acceptable salt or ester thereof, optionally ethinyl estradiol or a pharmaceutically acceptable salt, ester or ether thereof, a surfactant and at least one pharmaceutically acceptable excipient, wherein the drospirenone has a surface area of less than 10,000 cm2/g.
L'invention concerne une composition pharmaceutique dosifiée orale à dissolution rapide, destinée à inhiber l'ovulation chez un mammifère. Cette composition contient de la drospirénone ou un sel ou un ester pharmaceutiquement acceptable de celle-ci, facultativement de l'éthinyl estradiol ou un sel, un ester ou un éther pharmaceutiquement acceptable de celui-ci, un tensioactif et au moins un excipient pharmaceutiquement acceptable, la drospirénone présentant une surface active inférieure à 10 000 cm2/g. |
---|---|
Bibliography: | Application Number: WO2006EP62848 |